The low density of deep trapping defects in metal halide perovskites (MHPs) is essential for high-performance optoelectronic devices. Shallow traps in MHPs are speculated to enhance charge recombination lifetime. However, chemical nature and distribution of these shallow traps as well as their impact on solar cell operation remain unknown. Herein, we report that shallow traps are much richer in MHPs than traditional semiconductors, and their density can be enhanced by >100 times through local surface strain, indicating that shallow traps are mainly located at the surface. The surface strain is introduced by anchoring two-amine-terminated molecules onto formamidinium cations, and the shallow traps are formed by the band edge downshifting toward defect levels. The high-density shallow traps temporarily hold one type of charge and increased the concentration of the other type of free carrier in working solar cells by keeping photogenerated charges from bimolecular recombination, resulting in a reduced open-circuit voltage loss to 317 mV.
{"title":"Enhancing charge-emitting shallow traps in metal halide perovskites by >100 times by surface strain","authors":"Ying Zhou, Hengkai Zhang, Yeming Xian, Zhifang Shi, Jean Noalick Aboa, Chengbin Fei, Guang Yang, Nengxu Li, Farida A. Selim, Yanfa Yan, Jinsong Huang","doi":"10.1016/j.joule.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.joule.2024.10.004","url":null,"abstract":"The low density of deep trapping defects in metal halide perovskites (MHPs) is essential for high-performance optoelectronic devices. Shallow traps in MHPs are speculated to enhance charge recombination lifetime. However, chemical nature and distribution of these shallow traps as well as their impact on solar cell operation remain unknown. Herein, we report that shallow traps are much richer in MHPs than traditional semiconductors, and their density can be enhanced by >100 times through local surface strain, indicating that shallow traps are mainly located at the surface. The surface strain is introduced by anchoring two-amine-terminated molecules onto formamidinium cations, and the shallow traps are formed by the band edge downshifting toward defect levels. The high-density shallow traps temporarily hold one type of charge and increased the concentration of the other type of free carrier in working solar cells by keeping photogenerated charges from bimolecular recombination, resulting in a reduced open-circuit voltage loss to 317 mV.","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"8 1","pages":""},"PeriodicalIF":39.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-25DOI: 10.1016/s2213-2600(24)00217-0
Sergio Harari, Davide Elia, Antonella Caminati, Jens Geginat, Francesca Luisi, Giuseppe Pelosi, Claudia Specchia, Olga Torre, Roberta Trevisan, Chiara Vasco, Maurizio Zompatori, Roberto Cassandro
<h3>Background</h3>Lymphangioleiomyomatosis is an ultra-rare disease mainly affecting women of childbearing age. The MILES trial showed the efficacy of sirolimus, an mTOR inhibitor, in stabilising lung function in patients with lymphangioleiomyomatosis. Drug toxicity and development of resistance are potential limitations of therapy with sirolimus. Nintedanib is a multikinase inhibitor that inhibits PDGFR, which is active in human and murine lymphangioleiomyomatosis lesions. We aimed to investigate the activity and safety of nintedanib in patients with lymphangioleiomyomatosis.<h3>Methods</h3>This phase 2, open-label, single-arm study was conducted at MultiMedica IRCCS, a national referral university centre for rare pulmonary diseases in Milan, Italy. Eligible participants were aged 18 years and older and had sporadic or tuberous sclerosis complex-associated lymphangioleiomyomatosis with progressive pulmonary function decline in the past year despite treatment with sirolimus or treatment naive. Patients received nintedanib 150 mg orally twice per day, with a possible reduction to 100 mg twice per day in case of side-effects or hepatoxicity, for 12 months, followed by a period of 12 additional months without study treatment. The primary endpoint was the change in FEV<sub>1</sub> (FEV<sub>1</sub> slope in L) over 12 months. This study is registered with <span><span>ClinicalTrials.gov</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span>, <span><span>NCT03062943</span><svg aria-label="Opens in new window" focusable="false" height="20" viewbox="0 0 8 8"><path d="M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z"></path></svg></span>.<h3>Findings</h3>From Oct 14, 2016, to Dec 13, 2019, 35 female patients (mean age 50 years [SD 11]) entered the study, 30 of whom were eligible and received nintedanib. After 12 months, 22 patients completed the treatment, 19 of whom also completed the 12 months of follow-up. FEV<sub>1</sub> remained stable after one year of treatment (predicted mean difference 0·001 L [95% CI –0·063 to 0·066]; p=0·97). During the 12 months off treatment, a slight decline in FEV<sub>1</sub> was observed (predicted mean difference –0·076 L [95% CI –0·149 to –0·004]; p=0·040). The most frequent adverse events were nausea (15 [50%] patients), diarrhoea (eight [26%]), and abdominal pain (two [7%]). No serious adverse events were observed during the treatment period.<h3>Interpretation</h3>Our findings suggest that nintedanib did not improve FEV<sub>1</sub>, but that the treatment was generally well tolerated. These results might support nintedanib as a second-line therapy in patients not controlled by standard treatment with mTOR inhibitors. Further investigation, such as a non-inferiority trial comparing nintedanib and sirolimus could help to better
{"title":"Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study","authors":"Sergio Harari, Davide Elia, Antonella Caminati, Jens Geginat, Francesca Luisi, Giuseppe Pelosi, Claudia Specchia, Olga Torre, Roberta Trevisan, Chiara Vasco, Maurizio Zompatori, Roberto Cassandro","doi":"10.1016/s2213-2600(24)00217-0","DOIUrl":"https://doi.org/10.1016/s2213-2600(24)00217-0","url":null,"abstract":"<h3>Background</h3>Lymphangioleiomyomatosis is an ultra-rare disease mainly affecting women of childbearing age. The MILES trial showed the efficacy of sirolimus, an mTOR inhibitor, in stabilising lung function in patients with lymphangioleiomyomatosis. Drug toxicity and development of resistance are potential limitations of therapy with sirolimus. Nintedanib is a multikinase inhibitor that inhibits PDGFR, which is active in human and murine lymphangioleiomyomatosis lesions. We aimed to investigate the activity and safety of nintedanib in patients with lymphangioleiomyomatosis.<h3>Methods</h3>This phase 2, open-label, single-arm study was conducted at MultiMedica IRCCS, a national referral university centre for rare pulmonary diseases in Milan, Italy. Eligible participants were aged 18 years and older and had sporadic or tuberous sclerosis complex-associated lymphangioleiomyomatosis with progressive pulmonary function decline in the past year despite treatment with sirolimus or treatment naive. Patients received nintedanib 150 mg orally twice per day, with a possible reduction to 100 mg twice per day in case of side-effects or hepatoxicity, for 12 months, followed by a period of 12 additional months without study treatment. The primary endpoint was the change in FEV<sub>1</sub> (FEV<sub>1</sub> slope in L) over 12 months. This study is registered with <span><span>ClinicalTrials.gov</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>, <span><span>NCT03062943</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>.<h3>Findings</h3>From Oct 14, 2016, to Dec 13, 2019, 35 female patients (mean age 50 years [SD 11]) entered the study, 30 of whom were eligible and received nintedanib. After 12 months, 22 patients completed the treatment, 19 of whom also completed the 12 months of follow-up. FEV<sub>1</sub> remained stable after one year of treatment (predicted mean difference 0·001 L [95% CI –0·063 to 0·066]; p=0·97). During the 12 months off treatment, a slight decline in FEV<sub>1</sub> was observed (predicted mean difference –0·076 L [95% CI –0·149 to –0·004]; p=0·040). The most frequent adverse events were nausea (15 [50%] patients), diarrhoea (eight [26%]), and abdominal pain (two [7%]). No serious adverse events were observed during the treatment period.<h3>Interpretation</h3>Our findings suggest that nintedanib did not improve FEV<sub>1</sub>, but that the treatment was generally well tolerated. These results might support nintedanib as a second-line therapy in patients not controlled by standard treatment with mTOR inhibitors. Further investigation, such as a non-inferiority trial comparing nintedanib and sirolimus could help to better","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"32 1","pages":""},"PeriodicalIF":76.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-25DOI: 10.1016/s2213-2600(24)00328-x
Maria Molina-Molina
No Abstract
无摘要
{"title":"The challenge of therapeutic options for patients with lymphangioleiomyomatosis","authors":"Maria Molina-Molina","doi":"10.1016/s2213-2600(24)00328-x","DOIUrl":"https://doi.org/10.1016/s2213-2600(24)00328-x","url":null,"abstract":"No Abstract","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"60 1","pages":""},"PeriodicalIF":76.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142490045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-25DOI: 10.1038/s41570-024-00661-8
Aisha N. Bismillah, Stephen D. P. Fielden
Multiple sclerosis (MS) is a degenerative disease of the central nervous system. Two early-career researchers in supramolecular chemistry share their experiences of navigating academia whilst managing MS.
{"title":"Holding your nerve in academia whilst managing multiple sclerosis","authors":"Aisha N. Bismillah, Stephen D. P. Fielden","doi":"10.1038/s41570-024-00661-8","DOIUrl":"10.1038/s41570-024-00661-8","url":null,"abstract":"Multiple sclerosis (MS) is a degenerative disease of the central nervous system. Two early-career researchers in supramolecular chemistry share their experiences of navigating academia whilst managing MS.","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"8 11","pages":"793-794"},"PeriodicalIF":38.1,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-23DOI: 10.1038/s41570-024-00658-3
Yuzhu Ma, Haitao Li, Jian Liu, Dongyuan Zhao
Porous nanoreactors mimic the structures and functions of cells, providing an adaptable material with multiple functions and effects. These reactors can be nanoscale containers and shuttles or catalytic centres, drawing in reactants for cascading reactions with multishelled designs. The detailed construction of multi-level reactors at the nanometre scale remains a great challenge, but to regulate the reaction pathways within a reactor, designs of great intricacy are required. In this Review, we define the basic structural characteristics of porous nanoreactors, while also discussing the design principles and synthetic chemistry of these structures with respect to their emerging applications in energy storage and heterogeneous catalysis. Finally, we describe the difficulties of the structural optimization of these reactors and propose possible ways to improve porous nanoreactor design for future applications.
{"title":"Understanding the chemistry of mesostructured porous nanoreactors","authors":"Yuzhu Ma, Haitao Li, Jian Liu, Dongyuan Zhao","doi":"10.1038/s41570-024-00658-3","DOIUrl":"https://doi.org/10.1038/s41570-024-00658-3","url":null,"abstract":"<p>Porous nanoreactors mimic the structures and functions of cells, providing an adaptable material with multiple functions and effects. These reactors can be nanoscale containers and shuttles or catalytic centres, drawing in reactants for cascading reactions with multishelled designs. The detailed construction of multi-level reactors at the nanometre scale remains a great challenge, but to regulate the reaction pathways within a reactor, designs of great intricacy are required. In this Review, we define the basic structural characteristics of porous nanoreactors, while also discussing the design principles and synthetic chemistry of these structures with respect to their emerging applications in energy storage and heterogeneous catalysis. Finally, we describe the difficulties of the structural optimization of these reactors and propose possible ways to improve porous nanoreactor design for future applications.</p><figure></figure>","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"63 1","pages":""},"PeriodicalIF":36.3,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142487657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-23DOI: 10.1016/j.joule.2024.09.011
Bradie S. Crandall, Marcus Harland-Dunaway, Robert E. Jinkerson, Feng Jiao
For millennia, humanity has depended on photosynthesis to cultivate crops and feed a growing population. However, the escalating challenges of climate change and global hunger now compel us to surpass the efficiency limitations of photosynthesis. Here, we propose the adoption of an electro-agriculture (electro-ag) framework that combines CO2 electrolysis with biological systems to enhance food production efficiency. Adopting a food system based entirely on electro-ag could reduce United States agricultural land use by 88%, freeing nearly half of the country’s land for ecosystem restoration and natural carbon sequestration. Electro-ag bypasses traditional photosynthesis, enabling food cultivation in non-arable urban centers, arid deserts, and even outer space environments. We offer a new strategy that improves energy efficiency by an order of magnitude compared with photosynthesis, along with essential guidance for developing electro-ag focused on staple crops, to maximize benefits for regions facing food insecurity. This innovative approach to agriculture holds significant promise in reducing environmental impacts, streamlining supply chains, and addressing the global food crisis.
{"title":"Electro-agriculture: Revolutionizing farming for a sustainable future","authors":"Bradie S. Crandall, Marcus Harland-Dunaway, Robert E. Jinkerson, Feng Jiao","doi":"10.1016/j.joule.2024.09.011","DOIUrl":"https://doi.org/10.1016/j.joule.2024.09.011","url":null,"abstract":"For millennia, humanity has depended on photosynthesis to cultivate crops and feed a growing population. However, the escalating challenges of climate change and global hunger now compel us to surpass the efficiency limitations of photosynthesis. Here, we propose the adoption of an electro-agriculture (electro-ag) framework that combines CO<sub>2</sub> electrolysis with biological systems to enhance food production efficiency. Adopting a food system based entirely on electro-ag could reduce United States agricultural land use by 88%, freeing nearly half of the country’s land for ecosystem restoration and natural carbon sequestration. Electro-ag bypasses traditional photosynthesis, enabling food cultivation in non-arable urban centers, arid deserts, and even outer space environments. We offer a new strategy that improves energy efficiency by an order of magnitude compared with photosynthesis, along with essential guidance for developing electro-ag focused on staple crops, to maximize benefits for regions facing food insecurity. This innovative approach to agriculture holds significant promise in reducing environmental impacts, streamlining supply chains, and addressing the global food crisis.","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"8 1","pages":""},"PeriodicalIF":39.8,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142487312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-23DOI: 10.1038/s41570-024-00667-2
Alexander Rosu-Finsen
Glass transition temperatures are determined through, for instance, calorimetry, but maybe machine learning models can predict them. Here, researchers test this idea with published data as input for the model, to find a close correlation between predicted and experimental values.
{"title":"An algorithmic looking glass for transitions","authors":"Alexander Rosu-Finsen","doi":"10.1038/s41570-024-00667-2","DOIUrl":"10.1038/s41570-024-00667-2","url":null,"abstract":"Glass transition temperatures are determined through, for instance, calorimetry, but maybe machine learning models can predict them. Here, researchers test this idea with published data as input for the model, to find a close correlation between predicted and experimental values. ","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"8 11","pages":"797-797"},"PeriodicalIF":38.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142487776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-23DOI: 10.1016/s2213-2600(24)00340-0
Bryant Furlow
No Abstract
无摘要
{"title":"Youth vaping rates drop in US, but experts remain concerned","authors":"Bryant Furlow","doi":"10.1016/s2213-2600(24)00340-0","DOIUrl":"https://doi.org/10.1016/s2213-2600(24)00340-0","url":null,"abstract":"No Abstract","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"9 1","pages":""},"PeriodicalIF":76.2,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142488801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.joule.2024.09.015
Yichong Cai, Hang Zhang, Tidong Wang, Shibo Xi, Yuxi Song, Sida Rong, Jin Ma, Zheng Han, Chee Tong John Low, Qing Wang, Ya Ji
Aqueous redox flow batteries (ARFBs) are promising long-duration energy storage systems but struggle with low-energy density due to the inherent properties of liquid electrolytes. Herein, we report a [Fe(CN)6]3−/4−-LiMnxFe1 − xPO4/Zn flow battery utilizing redox-targeting (RT) electrochemical-chemical loop, exhibiting an outstanding energy density of 118.3 Wh L−1, surpassing blank RFB by 5.6 times. Remarkably, the RT reaction between redox mediator [Fe(CN)6]3−/4− and solid energy booster LiMnxFe1 − xPO4 is directionally regulated, clearly revealing the quantitative relation between capacity enhancement and potential difference. Moreover, unprecedented Coulombic efficiency (99.9%), solid booster utilization (78.4%), and capacity retention (99.8% per cycle) are achieved at 10 mA cm−2. Intriguingly, operando synchrotron X-ray absorption spectroscopy unveils the reversible changes of the Fe–O and Fe–Fe bonds in the [Fe(CN)6]3−/4−-LiMnxFe1 − xPO4 RT system during real-time monitoring. This work suggests an appealing way for capacity enhancement in ARFBs and provides profound insight into the fundamental chemistry of the RT reaction in safe, energy-dense batteries.
{"title":"Directional regulation on single-molecule redox-targeting reaction in neutral zinc-iron flow batteries","authors":"Yichong Cai, Hang Zhang, Tidong Wang, Shibo Xi, Yuxi Song, Sida Rong, Jin Ma, Zheng Han, Chee Tong John Low, Qing Wang, Ya Ji","doi":"10.1016/j.joule.2024.09.015","DOIUrl":"https://doi.org/10.1016/j.joule.2024.09.015","url":null,"abstract":"Aqueous redox flow batteries (ARFBs) are promising long-duration energy storage systems but struggle with low-energy density due to the inherent properties of liquid electrolytes. Herein, we report a [Fe(CN)<sub>6</sub>]<sup>3−/4−</sup>-LiMn<sub>x</sub>Fe<sub>1 − x</sub>PO<sub>4</sub>/Zn flow battery utilizing redox-targeting (RT) electrochemical-chemical loop, exhibiting an outstanding energy density of 118.3 Wh L<sup>−1</sup>, surpassing blank RFB by 5.6 times. Remarkably, the RT reaction between redox mediator [Fe(CN)<sub>6</sub>]<sup>3−/4−</sup> and solid energy booster LiMn<sub>x</sub>Fe<sub>1 − x</sub>PO<sub>4</sub> is directionally regulated, clearly revealing the quantitative relation between capacity enhancement and potential difference. Moreover, unprecedented Coulombic efficiency (99.9%), solid booster utilization (78.4%), and capacity retention (99.8% per cycle) are achieved at 10 mA cm<sup>−2</sup>. Intriguingly, <em>operando</em> synchrotron X-ray absorption spectroscopy unveils the reversible changes of the Fe–O and Fe–Fe bonds in the [Fe(CN)<sub>6</sub>]<sup>3−/4−</sup>-LiMn<sub>x</sub>Fe<sub>1 − x</sub>PO<sub>4</sub> RT system during real-time monitoring. This work suggests an appealing way for capacity enhancement in ARFBs and provides profound insight into the fundamental chemistry of the RT reaction in safe, energy-dense batteries.","PeriodicalId":38,"journal":{"name":"European Journal of Inorganic Chemistry","volume":"25 1","pages":""},"PeriodicalIF":39.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142486563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：